Factors affecting the restenosis rate after percutaneous transluminal coronary angioplasty

Thrombosis Research

Volumn 74, Issue , 1994, Pages S55-S67

  R , Bach ^a   F , Jung ^b   I , Kohsiek ^b   C , Özbek ^b   S , Spitzer ^b   B , Scheller ^b   J , Dyckmans ^c   H , Schieffer ^b  

^a Cardiac Out Patient Centre   (Germany)

^b SAARLAND UNIVERSITY   (Germany)

^c St Ingbert County Hospital   (Germany)

Author keywords

diabetes; platelet aggregation; PTCA

Indexed keywords

ACETYLSALICYLIC ACID;

ANGIOGRAPHY; CLINICAL TRIAL; CONFERENCE PAPER; DIABETES MELLITUS; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STENOSIS; THROMBOCYTE FUNCTION;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; BLOOD PLATELETS; CORONARY DISEASE; DIABETES MELLITUS; FEMALE; FOLLOW-UP STUDIES; HUMAN; MALE; MIDDLE AGE; PLATELET ADHESIVENESS; PLATELET AGGREGATION; RECURRENCE; REGRESSION ANALYSIS; RISK FACTORS;

EID: 0028284165     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0049-3848(10)80007-6     Document Type: Article

References (61)

1. Intimai proliferation of smooth muscle cells as an explanation for recurrent coronary artery stenosis after percutaneous transluminal coronary angioplasty
2. Laboratory test results as predictors of recurrent coronary artery stenosis following angioplasty
3. Rheological properties of blood after diagnostic cardiac catheterization with iopromide (Ultravist ®370)
4. Characterisation of induction of protooncogene c-myc and cellular growth in human vascular smooth muscle cells by insulin and IGF-1
5. Percutaneous transluminal coronary angioplasty (PTCA) in patients with relative contraindications. Results of the National Heart, Lung and Blood Institute PTCA Registry
6. Restenosis: The clinical issues
7. Mechanics of balloon-angioplasty
8. Mechanics of angioplasty: An experimental approach
9. Coronary angioplasty: anti platelet therapy reduces acute complication but not restenosis (abstr.)
10. Importance of stenosis morphology in the estimation of restenosis risk after elective percutaneous transluminal coronary angioplasty
11. Prospects for the use of antagonists of the platelet glycoprotein IIb/IIIa receptor to prevent postangioplasty restenosis and thrombosis
12. Comparative safety and efficacy of percutaneous transluminal coronary angioplasty in men and in women
13. Coronary angioplasty for unstable angina: Immediate and late results in 200 consecutive patients with identification of risk factors for unfavourable early and late outcome
14. Quantitative changes in stenotic coronary artery lesions during follow-up after PTCA (abstr.)
15. Restenosis after balloon dilatation of coronary stenosis: Multivariante analysis of potential risk factors
16. Reccurrence of stenosis after coronary angioplasty
17. Increased frequency of restenosis in patients continuing to smoke cigarettes after percutaneous transluminal coronary angioplasty
18. Aspirin-Non-Responder und erhöhter Plasmaadrenalinspiegel
19. The platelet reactivity test - A useful "by-product" of the blood sampling procedure?
20. Longterm follow-up after percutaneous transluminal coronary angioplasty. The early Zurich experience
21. Determinants of restenosis after successful percutaneous transluminal coronary angioplasty (PTCA) (abstr.)
22. Restenosis after successful percutaneous transluminal coronary angioplasty: The Montreal Heart Institute experience
23. Time comse of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty
24. The prognostic significance of 50 % coronary stenosis in medically treated patients with coronary artery disease
25. A multivariante model for predicting the risk of restenosis after PTCA (abstr.)
26. Recurrent stenosis after coronary angioplasty (abstr)
27. Restenosis after percutaneous transluminal coronary angioplasty: A report from the PTCA Registry of National Heart, Lung and Blood Institute
28. How cumulative is a risk of restenosis with multilesion dilation (abstr) ?
29. thrombin and hyperplasia in restenosis after coronary angioplasty
30. Effect of plasma lipids on restenosis following coronary angioplasty (abstr)
31. Coronary restenosis rates in consecutive patient series one year post successful angioplasty (abstr)
32. Langzeitergebnisse nach Koronardilatation
33. Recurrence rate after successful coronary angioplasty
34. Criteria for primary success and long-term results. Analysis of 152 consecutive transluminal coronary angioplasties
35. Is restenosis after coronary angioplasty lesion-dependent or patient-dependent (abstr)
36. Multiple coronary angioplasty: A model to discriminate systemic and procedural factors related to restenosis
37. Restenosis after successful coronary angioplasty in patients with single-vessel disease
38. Coronary angioplasty: Clinical and angiographic follow-up
39. Follow-up clinical results in patients undergoing percutaneous transluminal coronary angioplasty
40. Coronary angioplasty: Increased restenosis rate in insulin dependent diabetics (abstr)
41. Cardiac catheterizations
42. Clinical and angiographic assessment six months after double vessel percutaneous coronary angioplasty
43. Repeat coronary angioplasty
44. Percutaneous transluminal coronary angioplasty for chronic total coronary arterial occlusion
45. Multiple vessel coronary angioplasty: classification, results and patterns of restenosis in 494 consecutive patients
46. A controlled trial of corticosteroids to prevent restenosis after coronary angioplasty
47. Restenosis and its determinants in first and repeat coronary angioplasty
48. Restenosis and successful angioplasty: Histologic-radiologic correlation
49. The pathogenesis of atherosclerosis
50. Early and late outcome of percutaneous transluminal coronary angioplasty for subacute and chronic total coronary occlusion
51. Plasma lipids and coronary angioplasty (abstr)
52. Langzeiterfolg nach Koronarangioplastie in Abhängigkeit von der Gefäßgröße
53. Platelet activation and secretion associated with emotional stress
54. Late restenosis after emergent coronary angioplasty for acute myocardial infarction: Comparison with elective coronary angioplasty
55. Einfluß der Blutentnahmetechnik (arteriell oder venös) auf die Fließfähigkeit des Blutes
56. Role of platelet-prostaglandin synthesis in shear-induced platelet alterations
57. Multilesion coronary angioplasty: clinical and angiographic follow-up
58. Restenosis 1 to 24 months after clinically successful coronary balloon angioplasty: A necrops study of 20 patients
59. A new method for the quantitative detection of platelet aggregates in patients with arterial insufficiency
60. The role of hydrodynamic factors in platelet activation and thrombotic events: The effects of shear stress of short duration
61. Predictive value of chest discomfort for restenosis following successful coronary angioplasty